| News

The future of work

15.09.2020

What are the implications of the big reset on the future of work? Frank Kumli takes a look at the challenges and opportunities we will face, be it globally or in the Basel Area.

Switzerland Innovation Park Basel at Novartis Campus

The post-covid world will be different

The potential disruption of economic activity is massive: will there be jobs in the future? How will automation and robotics change the job landscape? On top of that, we are now facing tremendous uncertainty regarding the impact of the pandemic on our economic environment and on the way we work.

The world is reacting, adapting and transforming fast. Work is being reorganized alongside three dimensions:

1. Organization of work: Moving to distributed work

Work moves towards a distributed workforce that reaches beyond the traditional environment. Take Novartis, for example. The pharma company from Basel has recently offered its 110’000 associates the choice to decide how, where and when they work to create the greatest impact for their role.

2. Employee well-being: Enabling individual resilience

The future of work in this distributed environment will include a stronger focus on employee wellbeing. It encompasses and strengthens the emotional and mental health of the collaborators.

3. Infrastructure: Ensuring the right enablers for distributed work

Office environments will represent much more than a workplace. Instead, the office can be understood as a place where employees and stakeholders come together to create value. New types of space will emerge. Accelerator and incubator spaces will become vital components of workplaces.

We can see a stronger focus on human centricity and experience in the workplace: The workplace becomes an environment that helps individuals and businesses craft and experience a rewarding fusion of life and work.

In terms of operational excellence and digitalization, it is obvious that companies are embracing technological advancements such as automation, robotics, and artificial intelligence to seamlessly enable distributed work.

Furthermore, the role of physical clusters is becoming more critical than ever to drive innovation and economic growth. The cluster becomes even more important in an environment where critical drivers of economic development, such as innovation and entrepreneurial risk-taking, are hindered by the uncertain macroeconomic context and by the arrangements resulting from the reorganization of work.

We believe that, in this context, industry clusters such as the Basel Area and supporting organizations are becoming more relevant than ever to catalyze innovation and drive economic development.
They enable to:

  1. drive forward a common vision of a desirable future of work that is adapted to the industries they are nurturing
  2. activate an environment for collaborative and entrepreneurial environment
  3. reinvent space (beyond offices) for innovation and to provide dedicated and purpose-built space for safe collaborative innovation.
  4. catalyze the development of infrastructure such as the GRID Campus of Collaboration to accelerate innovation and associated local economic development.

This text is a summary of the event Talk & Inspire that took place on 26 August 2020 by Frank Kumli who also moderated the event.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
Startups from the Basel Area ranked among the best
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Startups from the Basel Area ranked among the best

Startups from the Basel Area have been ranked highly in the TOP 100 Swiss Startup Award by Venturelab. The medtech...

Read More
Roche testing for coronavirus and flu simultaneously
Basel Area Business & Innovation, Innovation, Invest

Roche testing for coronavirus and flu simultaneously

The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that...

Read More
Hengrui Medicine sets up clinical research and development in Basel
Basel Area Business & Innovation, Innovation, Invest

Hengrui Medicine sets up clinical research and development in Basel

The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research...

Read More
1 2 3 34

Do you have a question? We'd like to hear from you.